Dr. Somerset is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
Denver, CO 80204Phone+1 303-602-6076
Education & Training
University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2013 - 2014
University of ColoradoResidency, Pathology-Anatomic and Clinical, 2009 - 2013- University of Colorado School of Medicine Anschutz Medical CampusClass of 2009
Certifications & Licensure
CO State Medical License 2012 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 80 citationsComprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.J.S. Ross, Kai Wang, Jo-Anne Vergilio, James Suh, Shakti H. Ramkissoon
Annals of Oncology. 2016-10-01 - 23 citationsInhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.Shilpa Bhatia, Jaspreet Sharma, Sanjana Bukkapatnam, Ayman Oweida, Andy Phan
Clinical Cancer Research. 2018-09-15 - 49 citationsWnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions.Phuong Le, Stephen B. Keysar, Bettina Miller, Justin R. Eagles, Tugs-Saikhan Chimed
Molecular Carcinogenesis. 2019-03-01
Journal Articles
- Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients with Oral Cavity CancerDing Ding, Whitney Sumner, David Raben, Mohammad Hararah, Jessica McDermott, Sana D Karam, Julie Goddard, Hilary Somerset, JAMA
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerHilary Somerset, Antonio Jimeno, David Raben, Sana D Karam, Dara L Aisner, Madeleine Kane, Carrie Marshall, Daniel W Bowles, Clinical Cancer Research
- Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck CancersSana D Karam, Dallin Milner, Hilary Somerset, Antonio Jimeno, David Raben, Clinical Cancer Research
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
